ImmuPharma plc is a pharmaceutical company focused on the development and commercialization of novel drugs to treat serious medical conditions. It operates through collaborations with research institutions, such as the CNRS in France, and manages the clinical development of drug candidates. The company seeks partnerships to advance its product pipeline and maintains a lean corporate structure to control costs. ImmuPharma serves patients, healthcare professionals, and payers primarily in the pharmaceutical sector.